Participants 55 97 6
patients with metastatic colorectal cancer
Participants 395 437 4
patients with metastatic colorectal cancer
Participants 459 898 6
Patients with metastatic colorectal cancer were treated with fluorouracil, leucovorin, and irinotecan and were also given ALVAC-CEA/B7.1 vaccine with or without tetanus toxoid adjuvant. Eligible patients were randomized to ALVAC followed by chemotherapy and booster vaccination (group 1), ALVAC and tetanus toxoid followed by chemotherapy (group 2), or chemotherapy alone followed by ALVAC in patients without disease progression (group 3)
Participants 1092 1137 5
One hundred eighteen patients were randomized
Participants 1949 1991 3
patients with metastatic colorectal cancer
